Vladimir Ponomarev

Memorial Sloan Kettering Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index6.2kcitations113works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(35), CAR-T cell therapy research(35), Cancer Research and Treatments(19), Immunotherapy and Immune Responses(14), bioluminescence and chemiluminescence research(13)

Publications113 total

Practical considerations for clinical translation of PET imaging of adoptive cell therapies
npj Imaging·2025· 1 citedOpen Access
Evaluating Alpha- and Beta- Emitting PSMA-617 Radiopharmaceuticals in a PSMA Heterogeneous Mouse Model
Nuclear Medicine and Biology·2025
P.02: A systematic scoping review of studies investigating the fate of cells administered in clinical and whole organ studies.
Transplantation·2025
Abstract 1534: Targeting oxygen consumption with metformin and phenformin have differential effects on immune cells in the tumor microenvironment
Cancer Research·2025
Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies
Theranostics·2024· 4 citedOpen Access
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
Molecular Imaging and Biology·2024· 1 citedOpen Access
Abstract 4053: Targeting oxygen consumption with metformin and phenformin have differential effects on immune cells in the tumor microenvironment
Cancer Research·2024· 1 cited
Abstract 4051: Optimizing breast cancer therapy by modulating oxygen consumption
Cancer Research·2024
Author Correction: T cell–encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
Nature Medicine·2024· 1 citedOpen Access
Author Correction: Senolytic CAR T cells reverse senescence-associated pathologies
Nature·2024· 5 citedOpen Access
Nuclear-based labeling of cellular immunotherapies: a simple protocol for preclinical use
2024Open Access
Multiplexed PET Imaging Based on Multiple Coincidences and Deep-Learning
2023
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy
Nuclear Medicine and Biology·2023
117.9: A systematic scoping review of studies investigating the fate of cells administered in clinical and whole organ studies
Transplantation·2023
Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies
2023· 2 citedOpen Access
Simultaneous quantitative imaging of two PET radiotracers via the detection of positron–electron annihilation and prompt gamma emissions
Nature Biomedical Engineering·2023· 75 citedOpen Access
Evaluation of a photodynamic therapy agent using a canine prostate cancer model
The Prostate·2023· 6 citedOpen Access
Abstract 2517: Optimizing breast cancer therapy by inhibiting the adenosine receptor and oxygen consumption
Cancer Research·2023· 1 cited
Imaging the immune cell in immunotherapy
Elsevier eBooks·2023· 2 cited
Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients
Journal for ImmunoTherapy of Cancer·2022· 24 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Ronald G. Blasberg(16), Inna Serganova(13), Mikhail Doubrovin(12), Michel Sadelain(9), Juri G. Gelovani(9), Jelena Vider(8), Tatiana Beresten(8), Julius Balatoni(8), Larissa Shenker(7), Vasilios Liapis(7), Andreas Evdokiou(7), Maxim A. Moroz(6), Shelley Hay(6), David M. Findlay(6), Irene Zinonos(6), Juan Zurita(5), Shangde Cai(5), Nagavarakishore Pillarsetty(5), Hedvig Hricak(5), Agatha Labrinidis(5)